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Reduced graphene oxide (rGO) is one of the
most promising nanomaterials for application in
cancer photothermal therapy (PTT).1 This na-
nomaterial has a high near infrared (NIR) ab-
sorption, producing, upon interaction with NIR
light, hyperthermia that can cause the death of
cancer cells.1 However, rGO is commonly pro-
duced using hazardous agents (e.g. hydrazine
hydrate), hindering its biocompatibility.2 Fur-
thermore, the broader use of rGO in cancer PTT
is also limited by its poor colloidal stability and
inability to target cancer cells.3 To address these
limitations, herein rGO was produced using an
environmentally-friendly reduction method and
was functionalized with a hyaluronic acid based
amphiphilic polymer (HA-rGO) for application
in targeted breast cancer PTT (Figure 1).2
For the production of rGO, the concentration of
L-ascorbic acid (1.5 and 3 mM) and the time of
reduction (30 to 120 min) were optimized. The
results revealed that by treating GO with 3 mM
of L-ascorbic acid for 60 minutes, at 80 ºC,
yields rGO with suitable NIR absorption (mass
extinction coefficient of 12.67 L/(g.cm)), at
808 nm) and adequate size distribution for pho-
tothermal applications. Subsequently, the at-
tained rGO was functionalized with an HA-
based amphiphilic polymer, leading to an im-
provement in nanomaterials’ colloidal stability
and cytocompatibility. The HA-rGO also
demonstrated a higher internalization in CD44
overexpressing cells, revealing its targeting ca-
pacity. Finally, the combination of HA-rGO and
NIR light (808 nm, 1.7 W/cm2, 5 min) decreased
cancer cells’ viability to about 6%, further con-
firming the potential of this nanomaterial for
cancer photothermal therapy.
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